ImmunoGen, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
IMGN Nasdaq 8731 http://www.immunogen.com 6.55 Stock Up +0.05

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ImmunoGen, Inc.

ImmunoGen, Inc. breached its 50 day moving average in a Bearish Manner : IMGN-US : September 22, 2017 - Sep 22nd, 2017 6:14 am
ImmunoGen Inc (IMGN): Risks You Need To Consider Before Buying - Sep 18th, 2017 6:13 pm
Is ImmunoGen Running Out of Steam, or Taking a Breather? - Sep 16th, 2017 8:31 am
Why Shares of ImmunoGen, Inc. Sank Today - Sep 12th, 2017 4:33 pm
Behind Jazz’s Strategic Collaboration with ImmunoGen - Sep 7th, 2017 2:35 pm
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences - Sep 5th, 2017 6:30 am
Bull of the Day: Jazz Pharmaceuticals (JAZZ) - Sep 5th, 2017 2:00 am
ImmunoGen Announces Agreements to Exchange $76.4 Million of Its 4.50% Convertible Senior Notes Due 2021 for Common Stock - Sep 1st, 2017 6:00 am
ETFs with exposure to ImmunoGen, Inc. : August 31, 2017 - Aug 31st, 2017 4:54 pm
Biotechs On The Move - Aug 31st, 2017 2:01 pm
ImmunoGen (IMGN) Up 17.7% Since Earnings Report: Can It Continue? - Aug 31st, 2017 9:53 am
Featured Company News - Jazz Pharma to Partner with ImmunoGen for the Development and Commercialization of Antibody-Drug Conjugate Products - Aug 31st, 2017 5:50 am
Why Investors Bid Immunogen Inc. Up Almost 12% Today - Aug 30th, 2017 3:39 pm
Harry Boxer’s four biotech stocks to watch - Aug 30th, 2017 10:00 am
Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule - Aug 30th, 2017 9:47 am
ImmunoGen (IMGN) in Focus: Stock Moves 17.3% Higher - Aug 30th, 2017 6:56 am
Today's Research Reports on Stocks to Watch: ImmunoGen, Inc. and Acorda Therapeutics Inc. - Aug 30th, 2017 6:20 am
ImmunoGen and Jazz Enter Into Global Collaboration - Aug 29th, 2017 8:10 am
Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers - Aug 29th, 2017 8:10 am
Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products - Aug 29th, 2017 4:30 am